To identify the downstream modulator of TARBP2, we determined the expression of several key factors that have been reported to modulate self-renewal and drug resistance of cancer cells, including SOX2, Nanog, OCT4, Lin28A, CCND1 [27,28,29,30]. This evidence concerns the gene TARBP2 and cancer.